The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi as the first needle-free treatment for severe low blood sugar levels (hypoglycaemia) in diabetics in the EU ...
4 Department of Surgical and Perioperative Sciences, Sports Medicine Unit, Umeå University, Umeå, Sweden Correspondence to Dr Patrik Danielson, Department of Integrative Medical Biology, Anatomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results